BST — Biotechnology Assets SA Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapNeutral

Annual balance sheet for Biotechnology Assets SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	6.47	0.596	1.72	0.8	0.417
Net Total Accounts Receivable
Net Total Receivables	15.9	2.75	2.69	2.32	3.34
Total Inventory
Total Current Assets	30.4	3.37	4.4	3.12	3.76
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	41.2	2.7	2.56	2.53	2.44
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	92.7	20.2	19.9	18.5	16.6
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	29	9.52	3.55	3.54	3.61
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	85	16.2	15.4	14.4	9.92
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	7.71	3.99	4.49	4.03	6.68
Total Liabilities & Shareholders' Equity	92.7	20.2	19.9	18.5	16.6
Total Common Shares Outstanding